The approval is for a “method patent,” said Kristina Trujillo, TNeuroPharma’s CEO. It’s licensed exclusively to TNeuroPharma for the company’s method of detecting T-cells in patients to diagnose and treat Alzheimer’s.
Source: The Business Journal
Albuquerque-based company lands patent for novel Alzheimer's technology
Published in Polvadera
More from PolvaderaMore posts in Polvadera »
- DXD Capital gives update on NE Heights development
- SFiFF makes MovieMaker's list of festivals worth the entry fee
- Meow Wolf CEO: Expansion plans 'unaltered' by cuts; Meow Wolf Workers Collective responds
- The Village in Rio Rancho set to welcome Blake's Lotaburger
- <b>New Mexico</b> launches new option for absentee ballot voters – KRQE
Be First to Comment